Virginia Economic Review

Our quarterly publication, Virginia Economic Review, provides an insider look at Virginia’s economy, its diverse array of world-class companies, its amazing talent, and its stunning natural beauty, as well as insights from national thought leaders.

Filter by Issue Date
Filter by Industries
Filter by Topic
See All VER Issues
Workforce
First Quarter 2026

Building a Sustainable Pharma Manufacturing Workforce

With recent investments in biopharma manufacturing, Virginia is meeting the moment with a major push to build its talent pipeline, launching new training programs and a dedicated workforce center to prepare workers for advanced manufacturing roles. As reshoring accelerates, the Commonwealth is…

Read More
Eric Arocho with module background
First Quarter 2026

Growing a Biopharma Ecosystem

Eric Arocho is associate vice president at Eli Lilly and Company and the site lead on the company’s facility in Goochland County, Virginia - announced last year. The Goochland facility, expected to be completed within the next five years, will produce both critical drug components and finished…

Read More
Roanoke Research
First Quarter 2026

Behind the Rise of a Research Center in Roanoke

Investments from Virginia Tech, Carilion support critical studies in brain, heart, and cancer issues.

Read More
Researcher At Medicines for All Institute, Virginia Commonwealth University
First Quarter 2026

Continuous Improvement

The pharmaceutical manufacturing innovation that came out of a Virginia university is changing the way medicines are made. The Commonwealth’s universities and the rest of its biopharma research community are making sure Virginia is ready to make the medicines of the future.

Read More
Blue bubbles with VA overlay
First Quarter 2026

Enabling Innovation

Across Virginia, local life sciences ecosystems are helping researchers connect with the funding and facilities they need to grow.

Read More
Reshoring Manufacturing
First Quarter 2026

Behind the Effort to Bring Drug Manufacturing Back to U.S. Shores

Merck, Eli Lilly, Astra Zenec and more have made investments to expand in Virginia, signalling a broader surge in U.S.-based biopharma manufacturing as major drugmakers invest billions to bring production stateside. Driven by pandemic-era supply chain risks and new policy incentives, a nationwide…

Read More
See All VER Issues

Podcasts

Pam Cheng

The Urgency of Building Healthier Communities

April 1, 2026

A Conversation With Pam Cheng, Executive Vice President of Global Operations and IT and Chief Sustainability Officer, AstraZeneca

Dave Maraldo

The History and Future of Pharmaceutical Manufacturing in Virginia

April 1, 2026

A Conversation With Dave Maraldo, Senior Vice President of Human Health Manufacturing Operations, Merck

Peter Beard

Putting Talent in the Right Place

January 5, 2026

A Conversation With Peter Beard, Vice President of Policy and Programs, U.S. Chamber of Commerce Foundation

View All Podcasts